EARLY DIAGNOSIS OF PROSTATE CANCER USING HISTOSCANNING DEVICE


Citar

Texto integral

Acesso aberto Acesso aberto
Acesso é fechado Acesso está concedido
Acesso é fechado Acesso é pago ou somente para assinantes

Resumo

For the purpose of improving diagnosis of prostate cancer (PC), the authors used an innovative HistoScanning device. According to the standard procedure accepted at the clinic, 326 patients admitted with suspected prostate cancer were evaluated. Patients with elevated prostate-specific antigen (PSA) were divided into three groups depending on the degree of its increase, which ranged from 1.09 to 209 ng/ml; Group 4 (conventional control) consisted of patients with BPH, and Group 5 (control) consisted of healthy men aged 21 to 28 years. At the next step, histoscanning was performed with construction of maps of the prostate, which was used when performing a biopsy. The results of histoscanning were compared with data of morphological examination of biopsy material, and with the data of visual and morphological studies of surgical specimens in patients undergoing radical prostatectomy. High diagnostic value of histoscanning was demonstrated, as even in patients of Group 1 sensitivity was 89%, specificity - 96%, in patients of Group 2 and 3 - 96 and 94%, 99 and 97%, respectively. False positive results occurred in 11% of cases, false negative - only in 0.6%.

Texto integral

Acesso é fechado

Bibliografia

  1. EAU, Guidelines, 2011.
  2. Болезни предстательной железы. Под ред. чл-корр. РАМН Ю. Г. Аляева. М., ГЭОТАР-Медиа, 2009.
  3. Аляев Ю. Г., Амосов А. В., Винаров А. З. и др. Трансректальная допплерография у больных с заболеваниями предстательной железы. ФГУИПП “Кострома”. 2004.
  4. National Institute for Health and Clinical Excellence (NICE) clinical guideline 58, Prostate Cancer: diagnosis and treatment, 2008.
  5. Braeckman J., Autier P., Zatura F. et al. Evaluation of HistoScanning™ for the detection, location and volume estimation of prostate cancer: Results of the open phase of the PHS-02 study. J. Clin. Oncol. 2011;29(Suppl. 7) abstr. 55.
  6. Вестник Российского онкологического научного центра им. Н. Н. Блохина РАМН. Под ред. М. И. Давыдова, Е. М. Аксель. 2006;17(13) :прил. 1.
  7. Boyle P., Ferlay J. Cancer incidence and mortality in Europe 2004. Ann. Oncol. 2005;16(3):481-488. http://www.ncbi.nlm.nih.gov/ pubmed/15718248]
  8. Аляев Ю. Г., Локшин К. Л. Допплерографическая оценка кровообращения предстательной железы при ее гиперплазии. Урология. 2001;1:10-13.
  9. Степанов В. Н., Франк Г. А., Дисноев Р. Р. Интраэпиталиальная неоплазия простаты. Урология и нефрология. 1999;1:16-19.

Arquivos suplementares

Arquivos suplementares
Ação
1. JATS XML

Declaração de direitos autorais © Bionika Media, 2012

Este site utiliza cookies

Ao continuar usando nosso site, você concorda com o procedimento de cookies que mantêm o site funcionando normalmente.

Informação sobre cookies